COMMUNIQUÉS West-GlobeNewswire

Norton Children’s announces new pediatric care campus, second dedicated pediatric hospital
11/06/2025
New campus will expand specialty care and research for children from across the region LOUISVILLE, Ky., June 11, 2025 (GLOBE NEWSWIRE) -- Norton Children’s , a comprehensive pediatric health care system based in [...]
RadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and Corporate Initiatives
11/06/2025
LOS ANGELES, June 11, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today announced that [...]
Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon’s Board of Directors
11/06/2025
CROWN POINT, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Neurodon Corp., a leader in the development of endoplasmic reticulum (ER) stress-targeted therapeutics for diabetes and neurodegeneration, welcomes Frederick [...]
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
11/06/2025
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ MediPharm ” or the “ Company ”), a pharmaceutical company specialized in precision-based cannabinoids, today [...]
Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders
11/06/2025
Leiden, the Netherlands, June 11, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all [...]
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
11/06/2025
CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of [...]
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025
11/06/2025
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025 NANTES, France, 11 juin 2025, 18 heures 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce l'annulation de la [...]
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
11/06/2025
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025 NANTES, France, June 11, 6:30 PM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the cancellation of the convening of the [...]
PAT (ALPAT) : Attribution gratuite de bons de souscription d'actions remboursables au bénéfice de tous les actionnaires de la Société
11/06/2025
Vandœuvre-lès-Nancy, le 11 juin 2025 – 19 : 00 (CET) Communiqué de presse Pour diffusion immédiate Attribution gratuite de bons de souscription d'actions remboursables au bénéfice de tous les actionnaires de la Société [...]
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
11/06/2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutions EINDHOVEN, The Netherlands, June 11, [...]
KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders
11/06/2025
RIYADH, Saudi Arabia, June 11, 2025 (GLOBE NEWSWIRE) -- In a landmark medical achievement, King Faisal Specialist Hospital & Research Centre (KFSHRC) has become the first institution in the Middle East to [...]
AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research
11/06/2025
$2 million in DoD funding enables the evaluation of SeaStar Medical’s SCD therapy in the setting of severe burns, inhalation injury, and sepsis SAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- [...]
IntelGenx Announces Rebranding to Nualtis, Signaling Strategic Evolution and Renewed Vision
11/06/2025
MONTREAL, June 11, 2025 (GLOBE NEWSWIRE) -- IntelGenx, a leader in oral thin film drug delivery, today announced its official rebrand to Nualtis, marking a pivotal step in the company’s transformation and long-term [...]
Artelo Biosciences Announces Reverse Stock Split
11/06/2025
Shares Expected to Begin Trading on a Split-Adjusted Basis on June 13, 2025 SOLANA BEACH, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company [...]
OKYO Pharma to Present at the Bio International Convention
11/06/2025
LONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a [...]
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
11/06/2025
Transaction brings OSA diagnostic revenue to Vivos, plus Vivos’ highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area Transaction also completes Vivos’ business model [...]
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
11/06/2025
SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively pursue FDA [...]
GraceMed announces appointment of Dan Pawliw as Chief Executive Officer
11/06/2025
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- GraceMed, a leading consolidator in the plastic surgery, dermatology, and medical aesthetics industry, is pleased to announce the appointment of Dan Pawliw as its new Chief [...]
Veru to Participate in the Virtual BTIG Obesity Health Forum
11/06/2025
MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]

Pages